Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
526.00    10.00 (1.94%)
Bid:
531.00
Ask:
533.00
Spread: 2.00 (0.377%)
Market Cap: £302.68m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Pure Protection Market Study Update

2 Feb 2026 07:00

RNS Number : 2775R
Mortgage Advice Bureau (Hldgs) PLC
02 February 2026
 

 

2 February 2026

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Group")

 

Pure Protection Market Study Update

 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L), a leading technology-driven UK mortgage network and broker, welcomes the publication by the Financial Conduct Authority ("FCA") of its interim report into the distribution of pure protection products to retail customers (the "Report").

 

The Report represents a positive development for MAB and reflects the constructive and ongoing dialogue the Group has maintained with the FCA.

 

The FCA concludes that, in many respects, the distribution of pure protection products is working well and delivering good consumer outcomes, supported by high claims acceptance rates and low complaint levels. It also indicates that it does not envisage significant market interventions.

 

In relation to pricing, the FCA observes that, on average, practices such as "loaded premiums" or restricted panels are not creating worse pricing outcomes for consumers. These findings align with MAB's long-standing approach to panel governance and fair value, with our Consumer Duty Fair Value Assessment providing a strong evidential foundation for continued investment in high-quality protection advice and consumer outcomes.

 

MAB welcomes these findings and remains committed to maintaining the highest standards of consumer outcomes and regulatory engagement, while continuing to support the development of the protection market and the reduction of the protection gap identified in the Report.

 

Peter Brodnicki, Founder and CEO, commented:

 

"The FCA's findings are a positive and reassuring outcome for the protection market and for firms that have consistently focused on delivering good consumer outcomes. Protection advice plays a critical role in supporting financial resilience, and intermediaries are central to helping customers access appropriate cover.

 

As discussed at our recent Capital Markets Update, protection is a strategic growth priority for MAB. We are investing in dedicated capability alongside our core mortgage proposition, and the FCA's recognition of the need to address the protection gap reinforces the long-term opportunity in this market. MAB is well-positioned to support customers while continuing to operate to the highest regulatory standard.

 

Periods of regulatory uncertainty have created an overhang for the sector. The FCA's continued emphasis on proportionate, outcomes-based regulation, including its work on the Mortgage Rule Review, is therefore welcome. A clear regulatory framework that balances consumer protection with sustainable growth is critical to improving access, choice and advice for borrowers."

 

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc

Via Camarco

Peter Brodnicki, Chief Executive Officer

Emilie McCarthy, Chief Financial Officer 

 

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Jason Grossman / Francis North

 

 

+44 (0) 20 7710 7600

Joint Broker

Berenberg

James Felix / Michael Burke / Dan Gee-Summons 

 

 

+44 (0) 20 3207 7800

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Thomas Philpott / Rob Parker

 

+44 (0) 20 7418 8900

Media Enquiries

Camarco

Tom Huddart / Letaba Rimell

 

 

mab@camarco.co.uk

Investor Relations

 

Investor.relations@mab.org.uk

About MAB:

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

Through its partner firms known as Appointed Representatives (ARs), MAB has over 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visit www.mortgageadvicebureau.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFLLBQLLEBBQ
Date   Source Headline
19th Jun 20264:24 pmRNSDirector/PDMR Shareholding
8th Jun 202611:22 amRNSDirector/PDMR Shareholding
1st Jun 20263:59 pmRNSDirectors' Shareholdings and PDMR notification
1st Jun 20262:53 pmRNSDirectorate change
21st May 20269:15 amRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSResult of AGM
20th May 20267:00 amRNSAGM Trading Statement
14th May 20269:12 amRNSHolding(s) in Company
1st May 202612:41 pmRNSDirector/PDMR Shareholding
1st May 20268:00 amRNSReadmission - Mortgage Advice Bureau (Hldgs) PLC
1st May 20267:00 amRNSAdmission to trading on the Main Market
28th Apr 20266:00 pmRNSMortgage Advice Bureau
27th Apr 202612:00 pmRNSPublication of Prospectus and Trading Update
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20265:14 pmRNSHolding(s) in Company
21st Apr 20265:37 pmRNSNotice of AGM
21st Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:49 pmRNSHolding(s) in Company
16th Apr 20263:03 pmRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSAcquisition of HomeOwners Alliance Ltd
13th Apr 202610:32 amRNSDirectors' Shareholdings and PDMR notification
10th Apr 202610:29 amRNSStandard form for notification of major holdings
10th Apr 202610:25 amRNSStandard form for notification of major holdings
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:23 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSLaunch of Share Buyback Programme
31st Mar 20267:00 amRNSUpdate on Move to the Main Market
30th Mar 20263:33 pmRNSStandard form for notification of major holdings
23rd Mar 20262:47 pmRNSBlock Listing Interim Review
18th Mar 20265:11 pmRNSDirector/PDMR Shareholding
17th Mar 202611:52 amRNSNotification of Holding(s) in Company
17th Mar 20267:00 amRNSFinal Results
17th Mar 20267:00 amRNSFinal Results
3rd Mar 202612:15 pmRNSDirectors' Shareholdings and PDMR notification
26th Feb 20263:46 pmRNSTR-1: Notification of major holdings
24th Feb 20267:00 amRNS-RNotice of Final Results 2025 Investor Presentation
17th Feb 202611:13 amRNSDirectors' Shareholdings and PDMR notification
11th Feb 20263:19 pmRNSNotification of major holdings
6th Feb 20262:39 pmRNSChanges to concert party
2nd Feb 20264:40 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20267:00 amRNSPure Protection Market Study Update
28th Jan 20267:00 amRNSCapital Markets Update
27th Jan 20263:38 pmRNSDirectors' Shareholdings and PDMR notification
22nd Jan 20267:00 amRNSTrading Update
5th Jan 20264:47 pmRNSTotal Voting Rights
23rd Dec 20254:25 pmRNSIssuance of Shares and Total Voting Rights
23rd Dec 20254:25 pmRNSIssuance of Shares and Total Voting Rights
17th Dec 202512:01 pmRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirectorate changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.